Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Somatization in major depression--clinical features and genetic associations.

Klengel T, Heck A, Pfister H, Brückl T, Hennings JM, Menke A, Czamara D, Müller-Myhsok B, Ising M.

Acta Psychiatr Scand. 2011 Oct;124(4):317-28. doi: 10.1111/j.1600-0447.2011.01743.x. Epub 2011 Aug 13.

PMID:
21838737
2.

Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.

Xu Z, Zhang Z, Shi Y, Pu M, Yuan Y, Zhang X, Li L.

J Affect Disord. 2011 Sep;133(1-2):165-73. doi: 10.1016/j.jad.2011.04.011. Epub 2011 Jun 16.

PMID:
21680027
3.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.

PMID:
20531207
4.

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.

Perlis RH, Fijal B, Adams DH, Sutton VK, Trivedi MH, Houston JP.

Biol Psychiatry. 2009 May 1;65(9):785-91. doi: 10.1016/j.biopsych.2008.10.002. Epub 2008 Dec 18.

PMID:
19095219
5.

TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.

Yoon HK, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):403-9. doi: 10.1016/j.pnpbp.2008.12.013. Epub 2009 Jan 1.

PMID:
19162119
6.

Serotonin-related gene pathways associated with undifferentiated somatoform disorder.

Koh KB, Choi EH, Lee YJ, Han M.

Psychiatry Res. 2011 Sep 30;189(2):246-50. doi: 10.1016/j.psychres.2011.04.002. Epub 2011 May 4.

PMID:
21531467
7.

The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.

Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Papageorgiou K, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2012 Apr;22(4):259-66. doi: 10.1016/j.euroneuro.2011.08.007. Epub 2011 Sep 21.

PMID:
21940152
8.

TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.

Yin L, Zhang YY, Zhang X, Yu T, He G, Sun XL.

Pharmacopsychiatry. 2015 May;48(3):95-103. doi: 10.1055/s-0034-1398508. Epub 2015 Feb 2.

PMID:
25642918
9.

Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder.

Koh KB, Kim CH, Choi EH, Lee YJ, Seo WY.

J Clin Psychiatry. 2012 May;73(5):e574-9. doi: 10.4088/JCP.11m07342.

PMID:
22697203
10.

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

Illi A, Setälä-Soikkeli E, Viikki M, Poutanen O, Huhtala H, Mononen N, Lehtimäki T, Leinonen E, Kampman O.

Neuroreport. 2009 Aug 5;20(12):1125-8. doi: 10.1097/WNR.0b013e32832eb708.

PMID:
19590397
11.

Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response.

Xu Z, Zhang Z, Shi Y, Pu M, Yuan Y, Zhang X, Li L, Reynolds GP.

J Psychopharmacol. 2012 Mar;26(3):349-59. doi: 10.1177/0269881111414452. Epub 2011 Sep 21.

PMID:
21937687
12.

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.

Lin E, Chen PS, Chang HH, Gean PW, Tsai HC, Yang YK, Lu RB.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1167-72. doi: 10.1016/j.pnpbp.2009.06.015. Epub 2009 Jun 26.

PMID:
19560507
13.

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.

Horstmann S, Lucae S, Menke A, Hennings JM, Ising M, Roeske D, Müller-Myhsok B, Holsboer F, Binder EB.

Neuropsychopharmacology. 2010 Feb;35(3):727-40. doi: 10.1038/npp.2009.180. Epub 2009 Nov 18.

14.

Investigation of serotonin-related genes in antidepressant response.

Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP.

Mol Psychiatry. 2004 Sep;9(9):879-89.

PMID:
15052272
15.

Norepinephrine and serotonin transporter genes: impact on treatment response in depression.

Baffa A, Hohoff C, Baune BT, Müller-Tidow C, Tidow N, Freitag C, Zwanzger P, Deckert J, Arolt V, Domschke K.

Neuropsychobiology. 2010;62(2):121-31. doi: 10.1159/000317285. Epub 2010 Jun 30.

16.

Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.

Serretti A, Artioli P, Zanardi R, Lorenzi C, Rossini D, Cusin C, Arnoldi A, Catalano M.

Psychopharmacology (Berl). 2004 Aug;174(4):504-11. Epub 2004 Jul 10.

PMID:
15248044
17.

The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women.

Różycka A, Słopień R, Słopień A, Dorszewska J, Seremak-Mrozikiewicz A, Lianeri M, Maciukiewicz M, Warenik-Szymankiewicz A, Grzelak T, Kurzawińska G, Drews K, Klejewski A, Jagodziński PP.

Maturitas. 2016 Feb;84:42-54. doi: 10.1016/j.maturitas.2015.10.011. Epub 2015 Oct 30.

PMID:
26620113
18.

Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1.

Secher A, Bukh J, Bock C, Koefoed P, Rasmussen HB, Werge T, Kessing LV, Mellerup E.

Int Clin Psychopharmacol. 2009 Jul;24(4):199-203. doi: 10.1097/YIC.0b013e32832d6be2.

PMID:
19474754
19.

The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.

Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE.

Int Clin Psychopharmacol. 2005 Mar;20(2):87-91.

PMID:
15729083
20.

Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.

Houston JP, Kohler J, Ostbye KM, Heinloth A, Perlis RH.

Psychiatry Res. 2011 Oct 30;189(3):475-7. doi: 10.1016/j.psychres.2011.07.002. Epub 2011 Jul 24.

PMID:
21788083

Supplemental Content

Support Center